Drugs Approved for Multicentric Castleman Disease - National Cancer Institute

Drugs Approved for Multicentric Castleman Disease - National Cancer Institute

Drugs Approved for Multicentric Castleman Disease

This page lists cancer drugs approved by the Food and Drug Administration (FDA) for multicentric Castleman disease. The list includes generic names and brand names. The drug names link to NCI’s Cancer Drug Information summaries. There may be drugs used in multicentric Castleman disease that are not listed here.

Drugs Approved for Multicentric Castleman Disease

• Siltuximab
• Sylvant (Siltuximab)